GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (NAS:SLGL) » Definitions » Short Interest

Sol-Gel Technologies (Sol-Gel Technologies) Short Interest


View and export this data going back to 2018. Start your Free Trial

What is Sol-Gel Technologies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Sol-Gel Technologies's Short Interest

For the Biotechnology subindustry, Sol-Gel Technologies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sol-Gel Technologies's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sol-Gel Technologies's Short Interest distribution charts can be found below:

* The bar in red indicates where Sol-Gel Technologies's Short Interest falls into.


Sol-Gel Technologies (Sol-Gel Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sol-Gel Technologies Ltd (NAS:SLGL) » Definitions » Short Interest
Comparable Companies
VTVT DTIL BSEM HOOK INKT GANX ELDN PASG BOLT LPTX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
4SG:Germany 4SG:Germany
Address
7 Golda Meir Street, Weizmann Science Park, Ness Ziona, ISR, 7403650
Website
https://www.sol-gel.com
Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.